Who are we missing: Does engagement in patient-reported outcome measures for breast cancer vary by age, race, and disease stage? Journal Article
| Authors: | Srour, M. K.; Tadros, A. B.; Sevilimedu, V.; Nelson, J. A.; Cracchiolo, J. R.; McCready, T. M.; Silva, N.; Moo, T. A.; Morrow, M. |
| Article Title: | Who are we missing: Does engagement in patient-reported outcome measures for breast cancer vary by age, race, and disease stage? |
| Abstract: | Introduction: Patient-reported outcome measures (PROM) are used to assess value-based care. Little is known as to whether PROM response in breast cancer reflects the diverse patient population. The BREAST-Q, a validated measure of satisfaction and quality of life, and Recovery Tracker, a postoperative assessment tool, are PROM routinely delivered to all patients undergoing breast surgery at our institution. Here we determine whether response to PROM differs by age, race, language, or disease stage. Methods: All patients who had a breast operation between January 2020 and July 2021 were requested to complete the BREAST-Q and Recovery Tracker. Non-responders did not complete the PROM at any timepoint; responders completed 1 or more. Primary outcomes included rates of non-response versus response overall. Results: Of 6374 patients identified, 5653 (88.7%) responded to either PROM [4366/4751 (91.9%) BREAST-Q; 2746/3384 (81.1%) Recovery Tracker]. On univariate analysis, non-responders were older (60 years versus 55 years, p < 0.001) and more often non-English speaking (p < 0.001), Hispanic ethnicity (p = 0.031), and Black race (p < 0.001), versus responders. On multivariate analysis, non-responders were significantly more often Black race and non-English speaking (p < 0.001). Non-English speakers were significantly less responsive among all ethnicities and races except Black race. Although breast cancer stage did not reach significance for response, patients with malignant disease and those receiving neoadjuvant chemotherapy responded more often. Conclusions: Our findings demonstrate high patient engagement using 2 different PROM following breast surgery, but suggest that PROM results may not reflect the experience of the entire breast cancer population. Care process changes based solely on PROM should consider these findings to ensure that the views of the entire spectrum of patients with breast cancer are represented. © 2022, Society of Surgical Oncology. |
| Keywords: | adult; controlled study; aged; middle aged; cancer surgery; major clinical study; postoperative period; neoadjuvant therapy; cancer staging; antineoplastic agent; quality of life; breast cancer; mastectomy; cohort analysis; health survey; breast neoplasms; age; health care utilization; breast tumor; neoadjuvant chemotherapy; patient reported outcome measures; language; race difference; ethnicity; lumpectomy; hispanic; american indian; pacific islander; unemployment; patient-reported outcome; breast-q; humans; human; female; article; black person; english (language); spanish (language); native hawaiian |
| Journal Title: | Annals of Surgical Oncology |
| Volume: | 29 |
| Issue: | 13 |
| ISSN: | 1068-9265 |
| Publisher: | Springer |
| Date Published: | 2022-01-01 |
| Start Page: | 7964 |
| End Page: | 7973 |
| Language: | English |
| DOI: | 10.1245/s10434-022-12477-1 |
| PUBMED: | 36149608 |
| PROVIDER: | scopus |
| PMCID: | PMC10328095 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 December 2022 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work